← All educational resources

Anxiety That Is Not Psychological: The Body Reasons You Feel Afraid for No Reason

2026-11-21

Same post, two depths. Switch any time; the research version has the enzyme names, lab markers, and doses. Written from a research and education perspective: a model of what may be going on and what the published literature suggests would address it if the model is right, not medical advice or a treatment plan.

There is a kind of anxiety that has a story: a job, a relationship, a diagnosis, a past. Therapy helps with that kind, and this page is not about it.

There is another kind that arrives without a story. Your heart is pounding at 3 am and nothing is wrong. You feel dread before breakfast. You get shaky and panicky two hours after lunch, or after a glass of wine, or standing in line, or the week before your period, and the thoughts come after the feeling, scrambling to explain it. People with this kind get told it is anxiety, get offered an SSRI, and often get partly better, because the drug raises the threshold for everything. But the cause was never in the mind. It was in the body, and the body has a short list of ways to make you feel afraid.

This page is that list. Each item has a signature, a test, and a lever. Most people with the second kind of anxiety have two or three of them stacked.

How the body makes fear

The feeling of anxiety is built from a few ingredients: adrenaline and noradrenaline (the fight-or-flight chemicals), a fast heart, a low or crashing blood sugar, histamine, and a brain whose brake (GABA) is weaker than its accelerator (glutamate). The neurotransmitter map here covers the brain side in detail. The point is that anything that raises adrenaline, drops blood sugar, releases histamine, or weakens GABA will produce the physical feeling of fear, and the mind will supply a reason.

The list

1. Blood sugar crashes

The most common one and the most missed. Two to four hours after a high-carbohydrate meal, or after skipping one, blood sugar dips and the body releases adrenaline and cortisol to bring it back up. That adrenaline is the panic. The signature is timing: anxiety that comes mid-morning after a pastry breakfast, mid-afternoon, at 3 am, or whenever you have gone too long without eating, with shakiness, sweating, and sudden hunger, and that lifts within twenty minutes of food.

Test: a two-week glucose monitor, or simply a log of meals against anxiety episodes. Lever: protein at every meal, no sugar-only snacks, no skipped breakfast, and the substrate separation here pattern; the metabolic slide here if fasting insulin is up.

2. Histamine and mast cells

Histamine is a wake-up and alarm chemical in the brain, and mast cells release it in response to stress, estrogen, heat, exercise, and high-histamine food. The signature: anxiety with flushing, itching, hives, a racing heart after meals or wine, nasal congestion, worse at ovulation and before the period, worse in heat, often with insomnia or the 3am post here pattern. Many people with mast cell activation are first diagnosed with panic disorder.

Test: the four-week low-histamine trial here, and the mast cell markers in the mast cell post here. Lever: the trial, DAO with meals, an H1 antihistamine as a diagnostic (if cetirizine or fexofenadine calms the anxiety, that is informative), and the mast cell stabilizers.

3. Low magnesium

Magnesium is the brake on the glutamate receptor and the cofactor for making GABA. Low magnesium produces a jittery, over-stimulated, can't-settle anxiety with muscle twitching, cramps, palpitations, sensitivity to noise, and poor sleep. It is drained by stress hormones themselves, by alcohol, coffee, diuretics, and acid blockers, and by sweat.

Test: RBC magnesium (serum misses it). Lever: magnesium glycinate 300 to 400 mg, split, with the evening dose larger. In trials, magnesium improves anxiety scores in people who are low.

4. Low B6, and the GABA factory

GABA is made from glutamate by an enzyme that needs vitamin B6 in its active form (P5P), plus magnesium and zinc. Without enough B6, glutamate (the accelerator) builds up and GABA (the brake) runs short. B6 is drained by oral contraceptives, by high protein turnover, and by alcohol. The signature: anxiety with irritability, poor dream recall, PMS, and sometimes the carpal tunnel and mouth-corner cracks of deficiency.

Test: plasma P5P, or urinary xanthurenate and kynurenate on an organic acids test. Lever: P5P 25 to 50 mg, zinc 15 to 25 mg with copper, and the magnesium above. Too much B6 (over 100 mg a day for months) causes nerve damage, so this is not a more-is-better nutrient.

5. Too much adrenaline: the autonomic picture

POTS, hyperadrenergic dysautonomia, and the aftermath of long COVID all produce surges of noradrenaline on standing, after meals, and at night. The signature: anxiety that is worse upright and better lying down, a heart rate that jumps 30 or more on standing, tremor, sweating, cold hands, and panic attacks that start with the heart rather than the thought. This is the pots post here, and it is one of the most common findings in people with "treatment-resistant anxiety."

Test: a ten-minute stand test at home (lying heart rate, then standing at 1, 3, 5, and 10 minutes). Lever: everything in the POTS post, especially salt and fluids, compression, the breathing practice, and the nerve-repair nutrients; low-dose propranolol or clonidine through a clinician if the adrenergic surge is confirmed.

6. Thyroid, both directions

An over-active thyroid produces anxiety, tremor, heat intolerance, weight loss, and a fast heart, and is often missed in its mild form or in the swings of early Hashimoto's. An under-active one, or the low T3 pattern here, produces a slower, heavier, dread-type anxiety with fatigue and cold. Both are easy to test and worth testing every time.

Test: TSH, free T4, free T3, TPO and thyroglobulin antibodies.

7. Low iron

Iron builds dopamine, serotonin, and noradrenaline, and carries oxygen. Low ferritin produces a restless, breathless, racing-heart anxiety with poor exercise tolerance, restless legs, and a worse version of every other item on this list. Common in women with heavy periods and in anyone with low stomach acid or a gut problem. The ferritin post here.

Test: ferritin, transferrin saturation, CRP. Lever: replete to over 50, every-other-day iron with vitamin C, after the cause is found.

8. Caffeine and the slow clearers

Caffeine raises adrenaline and blocks the brain's sleepiness signal; in people with the slow CYP1A2 gene variant it lingers for 8 to 12 hours. The signature: anxiety that tracks coffee timing, worse with a second cup, with poor sleep onset. Alcohol is the mirror image: it calms for two hours through GABA and then rebounds with glutamate and histamine, producing the 3 am panic and the next-day dread. The pharmacogenomics here report covers both.

Test: two weeks without, then a single dose and a log. Lever: one low dose before noon, or none; alcohol not within four hours of bed, or not at all during the trial.

9. Breathing

Fast, shallow, upper-chest breathing (common in anxiety, POTS, hypermobility, and after respiratory illness) blows off carbon dioxide, which tightens blood vessels to the brain, tingles the hands, and produces lightheadedness and a sense of doom. The signature: sighing, yawning, air hunger, tingling, dizziness, chest tightness without a cardiac cause. It is both a cause and a result of the other items.

Test: can you breathe slowly through the nose for two minutes without air hunger? Lever: slow nasal breathing, four seconds in and six out, twice a day for five minutes; it is one of the few interventions with evidence for lowering the baseline adrenergic tone, and it is free.

10. Sleep loss and the cortisol rhythm

A week of six-hour nights raises baseline cortisol and adrenaline and lowers the threshold for everything above. Apnea does the same with a dozen micro-wakings an hour. The signature: anxiety that is worst in the morning or after a bad night, with brain fog and a wired-but-tired feeling.

Test: a sleep diary; a sleep study if snoring or unrefreshing sleep. Lever: the sleep rules in the 3am post, apnea treated.

11. The methylation and COMT piece

COMT clears adrenaline, noradrenaline, dopamine, and estrogen. The slow version (met/met) keeps them around longer, which makes a person more sensitive to stress, caffeine, and estrogen swings, and more likely to feel over-stimulated by methyl donors, stimulants, and even green tea extract. The signature: a lifelong tendency to anxiety that worsens with stimulants and improves with magnesium, and a bad reaction to methylfolate or SAMe. The neurotransmitters here report covers COMT, MAOA, and the GABA receptor genes.

12. Medications and withdrawal

Steroids, albuterol, decongestants, thyroid medication at too high a dose, some antidepressants in the first two weeks, stimulants, and withdrawal from benzodiazepines, alcohol, gabapentin, or an SSRI stopped too fast all produce anxiety directly. The medications table here lists the depletions; the point here is that any new anxiety within a month of a medication change goes back to the prescriber before it goes anywhere else.

How to work through it

  1. Keep a one-line log for two weeks: anxiety score, what you ate and when, sleep hours, caffeine, alcohol, cycle day, and whether you were upright. The timing will point at one or two items on the list.
  2. Draw the panel once: ferritin with saturation and CRP, full thyroid, RBC magnesium, P5P, fasting insulin and glucose, B12 (MMA), vitamin D. Add the mast cell markers if the histamine signature is there.
  3. Fix the cheapest things first: breakfast with protein, no sugar-only snacks, caffeine before noon or none, alcohol out for the trial, slow breathing twice a day, a fixed wake time. These cost nothing and clear half the list.
  4. Then the nutrients the panel points at: magnesium, P5P and zinc, iron, vitamin D.
  5. Then the trials: the low-histamine trial if the signature fits; the stand test if the autonomic signature fits.
  6. Keep the psychological help if you have it. The two kinds of anxiety coexist, therapy helps the first kind, and a calmer body makes therapy work better.

What this is not

Not a reason to stop a psychiatric medication, and not a claim that all anxiety is nutritional. It is a list of the physical causes that are checked too rarely, each with a test. Panic with chest pain, fainting, or a heart rate over 150 is an emergency department question, not a supplement question.

Educational content written from a research perspective, not medical advice. I am a PhD scientist, not a physician, and I do not diagnose, treat, cure, or prevent disease. Psychiatric medications are never stopped or changed without the prescriber. If you are in crisis, contact emergency services or a crisis line.

Framing

Anxiety is a final common pathway. The subjective state is assembled from locus coeruleus noradrenergic output, peripheral sympathetic activation, counter-regulatory responses to glycemic fall, central and peripheral histamine, and the balance of GABAergic inhibition against glutamatergic excitation in amygdala and prefrontal circuits (mapped in the neurotransmitter post here). Any physiological state that raises catecholamines, lowers glucose, releases histamine, or weakens GABA tone produces anxiety that is phenomenologically indistinguishable from psychogenic anxiety and that the patient will rationalize. The physiological differential is checked too rarely; a substantial fraction of "treatment-resistant" anxiety in referral populations carries one or more of the drivers below. This page is a differential with signatures, tests, and graded levers, written from a research perspective, not a treatment protocol.

The differential

1. Reactive and nocturnal hypoglycemia, and glycemic variability

Counter-regulation to a falling glucose (not only an absolute low; a rapid decline from a post-prandial peak suffices) releases epinephrine, norepinephrine, glucagon, and cortisol; adrenergic symptoms (tremor, palpitations, sweating, anxiety) appear at the catecholamine threshold, before neuroglycopenia. Signature: symptoms 2 to 4 hours after high-glycemic meals, with missed meals, mid-afternoon, or at 2 to 4 am (hepatic glycogen depletion; the 3am post here), relieved by food within 20 minutes. More common in early insulin resistance (delayed and exaggerated insulin response) and after bariatric surgery. Test: 14-day CGM with symptom marking; fasting insulin; a meal-and-symptom log. Lever: protein at each meal, no isolated carbohydrate, regular timing, the substrate separation here pattern; the metabolic slide here where insulin is elevated. Grade B.

2. Mast cell activation and histamine

Central histamine from the tuberomammillary nucleus is an arousal signal; peripheral mast cell mediators (histamine, PGD2, tryptase, cytokines) produce tachycardia, flushing, and vagal afferent signaling that the brain reads as threat; mast cell activation is recognized as a cause of panic-like episodes, and panic disorder is over-represented in mast cell cohorts. Signature: anxiety with flushing, pruritus, urticaria, rhinorrhea, post-prandial or alcohol-triggered tachycardia, heat intolerance, luteal and periovulatory worsening, sleep-maintenance insomnia. Test: the low-histamine trial here with rechallenge; plasma heparin, urinary N-methylhistamine and PGD2 metabolite, chromogranin A (tryptase is usually normal); an H1 antagonist trial as a probe. Lever: dietary trial, DAO, H1 and H2 antagonists, ketotifen or cromolyn, vitamin C, PLP, copper, the stabilizers in the mast cell post here. Grade B.

3. Magnesium insufficiency

Magnesium blocks NMDA receptors in a voltage-dependent manner, is a GAD cofactor, modulates the HPA axis (reduces ACTH release and adrenal sensitivity), and is depleted by catecholamines and cortisol themselves (urinary magnesium loss rises under stress), alcohol, caffeine, PPIs, loop and thiazide diuretics, and sweat. Signature: hyperexcitability (startle, noise sensitivity, fasciculation, cramps, palpitations), initial and maintenance insomnia, premenstrual worsening. Test: RBC magnesium (serum is maintained by bone efflux). Lever: magnesium glycinate or malate 300 to 400 mg elemental divided, larger dose at night; a 2017 systematic review found consistent improvement in subjective anxiety in magnesium-deficient and stress-vulnerable groups, with low-quality trials. Grade B in deficiency.

4. Pyridoxine status and GABA synthesis

GAD65 and GAD67 are PLP-dependent; the kynurenine pathway branch enzymes kynureninase and kynurenine aminotransferase are PLP-dependent, so B6 insufficiency raises xanthurenate and quinolinate (an NMDA agonist) and lowers kynurenate (an NMDA antagonist), shifting the excitatory balance. B6 is depleted by oral contraceptives, isoniazid, hydralazine, alcohol, and inflammation. Signature: anxiety with irritability, poor dream recall, premenstrual symptoms, glossitis or angular cheilitis, carpal tunnel. Test: plasma PLP (functional position over 50 nmol/L; under 30 is deficient); urinary xanthurenate and kynurenate after a tryptophan load or on an organic acids panel; low ALT. Lever: P5P 25 to 50 mg (toxicity, a sensory neuropathy, is reported with sustained intake over 100 mg, and sporadically at 50 mg in susceptible individuals, so dose is bounded and monitored), zinc 15 to 25 mg with copper, magnesium. Grade C for B6 alone, B as part of GABA-pathway repletion.

5. Hyperadrenergic autonomic states

Postural tachycardia syndrome (standing plasma norepinephrine over 600 pg/mL in the hyperadrenergic subtype; impaired vasoconstriction with compensatory sympathetic surge in the neuropathic subtype), inappropriate sinus tachycardia, post-viral dysautonomia, and baroreflex failure all produce episodic adrenergic activation that presents as panic. Signature: orthostatic worsening, heart rate rise of 30 bpm or more within 10 minutes of standing, tremor, diaphoresis, acrocyanosis, post-prandial and nocturnal episodes, episodes that begin with cardiac symptoms rather than cognition; frequent comorbidity with hypermobility and mast cell activation. Test: active stand test; supine and standing catecholamines; tilt table where indicated. Lever: the pots post here: volume and salt, compression, slow breathing, the small fiber nutrients, graded recumbent exercise; propranolol low dose, clonidine, ivabradine, or methyldopa by clinician for the hyperadrenergic phenotype. Grade B.

6. Thyroid dysfunction

Thyrotoxicosis (including subclinical hyperthyroidism and the hyperthyroid phase of Hashimoto's thyroiditis) produces beta-adrenergic sensitization, tremor, heat intolerance, palpitations, and anxiety; hypothyroidism and the ambulatory low T3 pattern produce a dysphoric, fatigued anxiety. Signature: weight change, temperature intolerance, pulse change, goiter, eye symptoms. Test: TSH, free T4, free T3, TPO and thyroglobulin antibodies, TSI where hyperthyroid. Lever: endocrine management; the low T3 post here for the conversion pattern. Grade A for testing.

7. Iron deficiency

Tyrosine and tryptophan hydroxylases are Fe2+ enzymes; iron deficiency without anemia reduces monoamine synthesis, increases adrenergic drive to maintain oxygen delivery, and is associated with anxiety and panic in cohort studies; restless legs and orthostatic tachycardia often coexist. Test: ferritin with transferrin saturation and CRP. Lever: the ferritin post here; repletion to over 50 ng/mL. Grade B.

8. Caffeine, alcohol, and clearance genotype

Caffeine antagonizes adenosine A1 and A2A receptors, raises catecholamines, and in CYP1A2 slow metabolizers (rs762551 C allele) has a prolonged half-life; doses over 200 mg reliably induce anxiety in panic-disorder populations and in ADORA2A variant carriers. Alcohol produces acute GABA-A potentiation and NMDA inhibition, then rebound glutamate excess, sympathetic activation, and histamine release during clearance (the mechanism of 3 am awakening and next-day anxiety). Test: structured withdrawal and rechallenge; CYP1A2 and ADORA2A genotype from the pharmacogenomics here report. Lever: caffeine under 100 to 200 mg before noon or none; alcohol withheld during any diagnostic trial. Grade A for caffeine in panic disorder.

9. Dysfunctional breathing and hypocapnia

Chronic upper-chest, high-frequency breathing lowers PaCO2, producing cerebral vasoconstriction, paresthesia, lightheadedness, chest tightness, and a sense of impending doom; it is common in anxiety, POTS, hypermobility (altered chest wall mechanics), and after respiratory infection, and it sustains the state it is a symptom of. Signature: sighing, air hunger, yawning, tingling, inability to tolerate slow nasal breathing. Test: Nijmegen questionnaire; breath-hold time; capnography where available. Lever: slow nasal breathing at about 6 breaths per minute, 5 minutes twice daily; breathing retraining has RCT support in panic disorder and in POTS, and resonance-frequency breathing raises HRV and baroreflex sensitivity. Grade B.

10. Sleep restriction, circadian disruption, and sleep apnea

Partial sleep restriction raises evening cortisol, sympathetic tone, and amygdala reactivity to negative stimuli within days; obstructive sleep apnea produces repetitive arousals with catecholamine surges and is associated with anxiety and panic, particularly nocturnal. Signature: morning-predominant anxiety, wired-but-tired state, snoring, unrefreshing sleep, nocturnal panic. Test: sleep diary or actigraphy; STOP-BANG; polysomnography. Lever: sleep extension and regularity, CBT-I, apnea treatment; CPAP reduces anxiety scores in treated cohorts. Grade B.

11. Catecholamine and estrogen clearance genotype

COMT Val158Met Met/Met carriers have lower enzyme activity, higher tonic prefrontal dopamine and slower clearance of norepinephrine and catechol estrogens, higher trait anxiety and pain sensitivity in several studies (the "worrier" phenotype), greater reactivity to stimulants and to methyl donors, and in some reports a paradoxical worsening of anxiety with high-dose methylfolate or SAMe. MAOA low-activity variants and GABRA2 and GAD1 polymorphisms modify the picture. These are modifiers, not diagnoses; they inform the choice of levers (magnesium, which COMT requires; avoidance of stimulant stacking; cautious titration of methyl donors). The neurotransmitters report here and the methylation report here cover the loci. Grade C as a modifier.

12. Iatrogenic and withdrawal causes

Glucocorticoids, beta-agonists, pseudoephedrine, levothyroxine over-replacement, stimulants, the first two weeks of SSRI or SNRI initiation (activation), bupropion, interferon, fluoroquinolones (GABA-A antagonism and NMDA agonism), montelukast, isotretinoin, and withdrawal from benzodiazepines, Z-drugs, alcohol, gabapentinoids, opioids, or abruptly stopped SSRIs and SNRIs. Nutrient depletion by medication is in the medications table here. Any new anxiety within weeks of a medication change returns to the prescriber first.

Less common but worth naming: pheochromocytoma (paroxysmal hypertension, headache, sweating; plasma free metanephrines), carcinoid, hypoparathyroidism and hypocalcemia (tetany, paresthesia), partial urea cycle limitation with post-prandial symptoms (the ammonia post here), Lyme and other infections, temporal lobe epilepsy (ictal fear), and the premonitory phase of migraine.

Working sequence

  1. Two-week log: anxiety score, meal timing and composition, sleep, caffeine, alcohol, cycle day, posture at onset, medications.
  2. Baseline panel: ferritin with saturation and CRP; TSH, free T4, free T3, antibodies; RBC magnesium; plasma PLP; fasting insulin and glucose, HbA1c; MMA and holotranscobalamin; 25-OH vitamin D; plasma zinc and copper; add mast cell mediators or plasma metanephrines where the signature fits. The lab guide here carries assay notes.
  3. Cost-free levers first: protein breakfast, regular meals, caffeine and alcohol regulation, slow breathing twice daily, fixed wake time.
  4. Repletion directed by the panel: magnesium, P5P and zinc, iron, vitamin D, B12.
  5. Diagnostic trials: low-histamine 4 weeks; active stand test; H1 antagonist probe.
  6. Psychological treatment is retained where in place; somatic correction increases its efficacy, and the two categories coexist in most people.

Markers that test the model

Anxiety scores (GAD-7) against the log over 8 to 12 weeks; the panel at 12 weeks; HRV (RMSSD) as an accessible index of autonomic balance; standing heart rate; CGM variability where glycemic drivers are suspected.

Educational and research content, not medical advice. The author holds a PhD in cellular and molecular nutrition, is not a licensed physician, and does not diagnose, treat, cure, or prevent disease. Psychotropic medication is never initiated, stopped, or changed without the prescribing clinician; acute chest pain, syncope, or sustained tachycardia require emergency evaluation.